Received: from DB5PR02MB11867.eurprd02.prod.outlook.com (2603:10a6:10:656::6) by VI1PR02MB5024.eurprd02.prod.outlook.com with HTTPS; Tue, 12 May 2026 08:17:45 +0000 Received: from GVXPR02MB12202.eurprd02.prod.outlook.com (2603:10a6:150:318::18) by DB5PR02MB11867.eurprd02.prod.outlook.com (2603:10a6:10:656::6) with Microsoft SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.20.9891.23; Tue, 12 May 2026 08:17:43 +0000 Received: from GVXPR02MB12202.eurprd02.prod.outlook.com ([fe80::7e68:6b0b:67d4:d05f]) by GVXPR02MB12202.eurprd02.prod.outlook.com ([fe80::7e68:6b0b:67d4:d05f%2]) with mapi id 15.20.9891.021; Tue, 12 May 2026 08:17:43 +0000 From: "Andrus Varki - RA" To: Cc: =?utf-8?Q?K=C3=A4rolin_Jenas_-_RA?= References: <0b1142f2de5b4ee9b77a206ee9671966@ravimiamet.ee> In-Reply-To: <0b1142f2de5b4ee9b77a206ee9671966@ravimiamet.ee> Subject: =?utf-8?Q?Ed:_Eeln=C3=B5u_edastamine_koosk=C3=B5last?= =?utf-8?Q?amiseks_ja_arvamuse_avaldamiseks?= Date: Tue, 12 May 2026 11:17:43 +0300 Message-ID: MIME-Version: 1.0 Content-Type: multipart/alternative; boundary="----=_NextPart_000_00AF_01DCE631.6A8DDBE0" X-Mailer: Microsoft Outlook 16.0 Thread-Index: AQIOkpl4/ke9+WNmGnvinYgaN9pG2wG7v7jt Authentication-Results: dkim=none (message not signed) header.d=none;dmarc=none action=none header.from=ravimiamet.ee; X-MS-Has-Attach: X-MS-TNEF-Correlator: x-ms-traffictypediagnostic: GVXPR02MB12202:EE_|DB5PR02MB11867:EE_|VI1PR02MB5024:EE_ X-MS-Office365-Filtering-Correlation-Id: 935dc301-fc3d-4c1d-855a-08deaffef0f0 X-MS-Exchange-AtpMessageProperties: SA X-MS-Exchange-Transport-CrossTenantHeadersStamped: DB5PR02MB11867 X-CodeTwoProcessed: true X-MS-Exchange-Organization-ExpirationStartTime: 12 May 2026 08:17:43.6762 (UTC) X-MS-Exchange-Organization-ExpirationStartTimeReason: OriginalSubmit X-MS-Exchange-Organization-ExpirationInterval: 1:00:00:00.0000000 X-MS-Exchange-Organization-ExpirationIntervalReason: OriginalSubmit X-MS-Exchange-Organization-Network-Message-Id: 935dc301-fc3d-4c1d-855a-08deaffef0f0 X-MS-Exchange-Organization-MessageDirectionality: Originating X-MS-Exchange-Organization-AuthAs: Internal X-MS-Exchange-Organization-AuthMechanism: 04 X-MS-Exchange-Organization-AuthSource: GVXPR02MB12202.eurprd02.prod.outlook.com X-MS-Exchange-Organization-SCL: 1 X-MS-PublicTrafficType: Email X-Microsoft-Antispam: BCL:0;ARA:13230040|366016|31052699007|39142699007|22082099003|56012099003|11063799003|55112099003|8096899003|13003099007|18002099003|41050700001; X-Forefront-Antispam-Report: CIP:255.255.255.255;CTRY:;LANG:ja;SCL:1;SRV:;IPV:NLI;SFV:NSPM;H:GVXPR02MB12202.eurprd02.prod.outlook.com;PTR:;CAT:NONE;SFS:(13230040)(366016)(31052699007)(39142699007)(22082099003)(56012099003)(11063799003)(55112099003)(8096899003)(13003099007)(18002099003)(41050700001);DIR:INT; X-MS-Exchange-CrossTenant-OriginalArrivalTime: 12 May 2026 08:17:43.1871 (UTC) X-MS-Exchange-CrossTenant-Network-Message-Id: 935dc301-fc3d-4c1d-855a-08deaffef0f0 X-MS-Exchange-CrossTenant-Id: 8fe098d2-428d-4bd4-9803-7195fe96f0e2 X-MS-Exchange-CrossTenant-AuthAs: Internal X-MS-Exchange-CrossTenant-AuthSource: GVXPR02MB12202.eurprd02.prod.outlook.com X-MS-Exchange-CrossTenant-FromEntityHeader: Hosted X-MS-Exchange-Transport-EndToEndLatency: 00:00:02.3991743 X-MS-Exchange-Processed-By-BccFoldering: 15.20.9891.020 X-MS-Exchange-ExternalInOutlookResult: NotEnabled X-Microsoft-Antispam-Mailbox-Delivery: ucf:0;jmr:0;auth:0;dest:I;ENG:(910005)(944506478)(944626604)(920097)(425001)(930201)(20251009189)(140003); X-Microsoft-Antispam-Message-Info: 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 Content-Language: et x-ms-exchange-organization-originalclientipaddress: 45.156.32.33 x-ms-exchange-organization-originalserveripaddress: 2603:10a6:150:318::18 acceptlanguage: et-EE, en-US msip_labels: MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_Enabled=True;MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_SiteId=8fe098d2-428d-4bd4-9803-7195fe96f0e2;MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_SetDate=2026-05-12T08:17:42.623Z;MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_Name=All Employees (unrestricted);MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_ContentBits=1;MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_Method=Standard; X-OlkEid: 000000004C30E2D3CD34B4428531CBEB8A7CAB89070034AD76187591974DBF6C4F76951C873A0100020000000000B04CDEF8D3227A448511457FBBCE9C870000000008BE00005FC5A07E958DB143943C3BF4A1DF7B72 X-MS-Exchange-Organization-ModifySensitivityLabel: 00000000-0000-0000-0000-000000000000;defa4170-0d19-0005-0004-bc88714345d2 x-codetwo-clientsignature-inserted: true X-MS-Exchange-CrossTenant-MailboxType: HOSTED X-MS-Exchange-CrossTenant-UserPrincipalName: HsRsKDFW3icjCqfOUZ0NPvfNm5Bguk/rcjYrM+jASRARUSLQy2iv9QT/10PXVd6BKqomxMtroaH1R0KhIUhF8bJ2VX3yvvuLB4lMx/8nRQ8= This is a multipart message in MIME format. ------=_NextPart_000_00AF_01DCE631.6A8DDBE0 Content-Type: text/plain; charset="utf-8" Content-Transfer-Encoding: 8bit Teie: 23.04.2026 nr 1-1/15-886-2 Meie: 12.05.2026 nr JUR-3/2373-2 Tere Ravimimetil ei ole tähelepanekuid. Lugupidamisega Andrus Varki juhataja Õigusosakond Ravimiamet 737 4140 www.ravimiamet.ee Selles e-kirjas sisalduv teave (kaasa arvatud manused) on mõeldud ametialaseks kasutamiseks ning seda võivad kasutada vaid e-kirja adressaadid. E-kirjas sisalduvat teavet ei tohi ilma saatja selgelt väljendatud loata edasi saata ega mis tahes viisil kolmandatele isikutele avaldada. Juhul, kui Te olete saanud käesoleva e-kirja eksituse tõttu, teavitage sellest koheselt saatjat ning kustutage e-kiri. This e-mail and any attachments transmitted may contain confidential and privileged information. If you are not the intended recipient, please notify the sender immediately by returning the e-mail and permanently deleting what you have received. Any dissemination or use of this information by a third person without permission is prohibited and may be illegal. ------=_NextPart_000_00AF_01DCE631.6A8DDBE0 Content-Type: text/html; charset="utf-8" Content-Transfer-Encoding: quoted-printable
Teie:      23.04.2026 nr 1-1/15-886-2
Meie:    12.05.2026 nr JUR-3/2373-2
 
Tere
Ravimimetil ei ole t=C3=A4helepanekuid.
 
Lugupidamisega

Andrus Varki

juhataja

=C3=95igusosakond


Ravimiamet

737 4140

www.ravimiamet.ee


Selles e-kirjas sisalduv teave (kaasa arvatud manused) on = m=C3=B5eldud ametialaseks kasutamiseks ning seda v=C3=B5ivad kasutada = vaid e-kirja adressaadid. E-kirjas sisalduvat teavet ei tohi ilma saatja = selgelt v=C3=A4ljendatud loata edasi saata ega mis tahes viisil = kolmandatele isikutele avaldada. Juhul, kui Te olete saanud = k=C3=A4esoleva e-kirja eksituse t=C3=B5ttu, teavitage sellest koheselt = saatjat ning kustutage e-kiri. 
This e-mail and any attachments transmitted may = contain confidential and privileged information. If you are not the = intended recipient, please notify the sender immediately by = returning the e-mail and permanently deleting what you have = received. Any dissemination or use of this information by a third person without permission is = prohibited and may be illegal. 



------=_NextPart_000_00AF_01DCE631.6A8DDBE0--